Related Experiment Video
Updated: Jul 13, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
The Influence of Human IgG Subclass and Allotype on Complement Activation.
Timon Damelang1,2,3, Steven W de Taeye1,2, Rosa Rentenaar1
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Structural variations in immunoglobulin G (IgG) allotypes significantly impact complement activation and complement-dependent cytotoxicity (CDC). Specific IgG2 variants and differences between IgG1 and IgG3 subclasses influence cell lysis, offering insights for therapeutic antibody design.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Complement activation via the classical pathway is initiated by C1 binding to oligomeric immunoglobulins (Igs) on target surfaces.
- Antibody (Ab) structure, including isotype, subclass, and glycosylation, influences complement system activation.
- Polymorphic variants of IgG can affect Fc-dependent effector functions.
Purpose of the Study:
- To assess complement binding, deposition, and complement-dependent cytotoxicity (CDC) of 27 known IgG allotypes with anti-trinitrophenyl specificity.
- To investigate the impact of structural variations within IgG subclasses on complement activation.
- To elucidate the context-dependent nature of antibody-mediated CDC.
Main Methods:
- Evaluation of complement binding and deposition across 27 IgG allotypes.
- Assessment of complement-dependent cytotoxicity (CDC) using various cell lines (human RBCs, Ramos, Raji, Wien133).
- Comparison of IgG1 and IgG3 subclasses under varying antigen density and in the presence/absence of complement regulators.
Main Results:
- Minor differences in complement activation were observed among IgG1, IgG3, and IgG4 allotypes, with more substantial variations in IgG2.
- Allelic variant IGHG2*06 demonstrated reduced complement activation and CDC compared to other IgG2 polymorphisms.
- Cell lysis varied between IgG1 and IgG3, with IgG3 showing superior lysis of RBCs and Ramos cells, while IgG1 was more effective against Raji and Wien133 cells.
- Antigen density and antibody hinge length, rather than complement regulators, determined the context-dependent CDC activity of IgG1 and IgG3.
Conclusions:
- Single amino acid changes and hinge length differences in IgG allotypes can alter their capacity to activate complement.
- These variations may provide new insights into susceptibility to infectious, alloimmune, and autoimmune diseases.
- Understanding these structural-functional relationships can aid in the design of improved antibody-based therapeutics.
More Related Videos
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Humoral Immune Responses
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Complement System
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

